FDA announced the Phase II report on their effort to increase transparency stating:“On May 19, 2010, the Transparency Task Force released a report containing 21 draft proposals about expanding the disclosure of information by FDA while maintaining confidentiality for trade secrets and individually identifiable patient information. FDA is accepting public comment on the content of the proposals, as well as on which draft proposals should be given priority, on this website until July 20, 2010.”
The FDA Report on the 21 Draft Proposals is available in PDF format.
The Blog will be reading the report carefully and urges you to do so as well.
UPDATE: In other news of interest FDA’s Principal Deputy Commissioner, Dr. Joshua M. Sharfstein, testified to Congress about the recall of adulterated Tylenol and other pediatric medicines. The New York Times reported that FDA is considering additional penalties including the possibility of criminal prosecution.